Genetic Signatures Limited (GSS.AX)

AUD 0.63

(-8.03%)

Revenue Summary of Genetic Signatures Limited

Genetic Signatures Limited's latest annual revenue in 2024 was 9.76 Million AUD , down -42.35% from previous year.
Genetic Signatures Limited's latest quarterly revenue in 2024 FY was 9.76 Million AUD , down -42.35% from previous quarter.
Genetic Signatures Limited reported a annual revenue of 16.93 Million AUD in annual revenue 2023, down -52.18% from previous year.
Genetic Signatures Limited reported a annual revenue of 35.42 Million AUD in annual revenue 2022, up 25.23% from previous year.
Genetic Signatures Limited reported a quarterly revenue of 3.6 Million AUD for 2024 Q2, down 0.0% from previous quarter.
Genetic Signatures Limited reported a quarterly revenue of 6.16 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of Genetic Signatures Limited (2024 - 2013)

Historical Annual Revenue of Genetic Signatures Limited (2024 - 2013)

Year	Revenue	Revenue Growth
2024	9.76 Million AUD	-42.35%
2023	16.93 Million AUD	-52.18%
2022	35.42 Million AUD	25.23%
2021	28.28 Million AUD	151.12%
2020	11.26 Million AUD	60.35%
2019	7.02 Million AUD	40.66%
2018	4.99 Million AUD	22.95%
2017	4.06 Million AUD	24.37%
2016	3.26 Million AUD	213.03%
2015	1.04 Million AUD	-19.28%
2014	1.29 Million AUD	402.97%
2013	256.97 Thousand AUD	0.0%

Year	Revenue	Revenue Growth
2024 FY	9.76 Million AUD	-42.35%
2024 Q2	3.6 Million AUD	0.0%
2024 Q4	6.16 Million AUD	0.0%
2023 Q4	6.53 Million AUD	0.0%
2023 FY	16.93 Million AUD	-52.18%
2023 Q2	10.4 Million AUD	0.0%
2022 Q4	13.58 Million AUD	0.0%
2022 FY	35.42 Million AUD	25.23%
2022 Q2	21.83 Million AUD	0.0%
2021 FY	28.28 Million AUD	151.12%
2021 Q4	9.59 Million AUD	0.0%
2021 Q2	18.69 Million AUD	0.0%
2020 Q2	2.53 Million AUD	0.0%
2020 FY	11.26 Million AUD	60.35%
2020 Q4	8.73 Million AUD	0.0%
2019 Q4	2.61 Million AUD	0.0%
2019 Q2	3.45 Million AUD	0.0%
2019 FY	7.02 Million AUD	40.66%
2018 Q4	2.53 Million AUD	0.0%
2018 Q2	2.45 Million AUD	0.0%
2018 FY	4.99 Million AUD	22.95%
2017 Q2	1.92 Million AUD	0.0%
2017 FY	4.06 Million AUD	24.37%
2017 Q4	2.13 Million AUD	0.0%
2016 Q2	1.5 Million AUD	0.0%
2016 Q4	1.76 Million AUD	0.0%
2016 FY	3.26 Million AUD	213.03%
2015 Q2	851.96 Thousand AUD	0.0%
2015 Q4	1.16 Million AUD	344.91%
2015 FY	1.04 Million AUD	-19.28%
2015 Q3	260.81 Thousand AUD	-69.39%
2015 Q1	- AUD	0.0%
2014 FY	1.29 Million AUD	402.97%
2014 Q2	- AUD	0.0%
2014 Q3	- AUD	0.0%
2014 Q4	- AUD	0.0%
2013 FY	256.97 Thousand AUD	0.0%

Peer Revenue Comparison of Genetic Signatures Limited

Name	Revenue	Revenue Difference
Australian Clinical Labs Limited	689.72 Million AUD	98.584%
BCAL Diagnostics Limited	3.09 Million AUD	-215.226%
Genetic Technologies Limited	7.66 Million AUD	-27.414%
Healius Limited	1.74 Billion AUD	99.441%
Imagion Biosystems Limited	1.36 Million AUD	-614.162%
Integral Diagnostics Limited	469.69 Million AUD	97.921%
INOVIQ Ltd	535.11 Thousand AUD	-1725.018%
Microba Life Sciences Limited	12.09 Million AUD	19.223%
Monash IVF Group Limited	254.96 Million AUD	96.17%
Rhythm Biosciences Limited	1.69 Million AUD	-477.821%
Sonic Healthcare Limited	8.93 Billion AUD	99.891%